LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 21.17 | 770.25 | 1647 | 2008 | 0.8201 | 0.7327 | MN20160304_L02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 23.39 | 770.25 | 1861 | 2244 | 0.8291 | 0.7713 | MN20160304_L02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 23.39 | 770.25 | 1756 | 2244 | 0.7824 | 0.7059 | MN20160304_L02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 25.62 | 770.25 | 2049 | 2514 | 0.8148 | 0.7738 | MN20160304_L02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 25.62 | 770.25 | 1948 | 2514 | 0.7746 | 0.7221 | MN20160304_L02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 27.84 | 770.25 | 2288 | 2833 | 0.8074 | 0.7848 | MN20160304_L02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 27.84 | 770.25 | 2167 | 2833 | 0.7647 | 0.7339 | MN20160304_L02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 30.06 | 770.25 | 2573 | 3106 | 0.8284 | 0.8213 | MN20160304_L02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 30.06 | 770.25 | 2407 | 3106 | 0.7749 | 0.7619 | MN20160304_L02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 32.28 | 770.25 | 2815 | 3392 | 0.8297 | 0.8328 | MN20160304_L02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 32.28 | 770.25 | 2594 | 3392 | 0.7645 | 0.7641 | MN20160304_L02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 34.50 | 770.25 | 3119 | 3712 | 0.8403 | 0.8523 | MN20160304_L02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 34.50 | 770.25 | 2819 | 3712 | 0.7594 | 0.7716 | MN20160304_L02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 36.73 | 770.25 | 3354 | 4086 | 0.8208 | 0.8425 | MN20160304_L02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 36.73 | 770.25 | 3045 | 4086 | 0.7452 | 0.7700 | MN20160304_L02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 38.95 | 770.25 | 3710 | 4543 | 0.8165 | 0.8477 | MN20160304_L02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 38.95 | 770.25 | 3383 | 4543 | 0.7445 | 0.7823 | MN20160304_L02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 41.17 | 770.25 | 4181 | 5010 | 0.8344 | 0.8704 | MN20160304_L02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 41.17 | 770.25 | 3820 | 5010 | 0.7624 | 0.8089 | MN20160304_L02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 43.39 | 770.25 | 4618 | 5404 | 0.8545 | 0.8912 | MN20160304_L02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 43.39 | 770.25 | 4176 | 5404 | 0.7727 | 0.8247 | MN20160304_L02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 45.61 | 770.25 | 4969 | 5813 | 0.8548 | 0.8952 | MN20160304_L02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 45.61 | 770.25 | 4481 | 5813 | 0.7709 | 0.8292 | MN20160304_L02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 47.83 | 770.25 | 5310 | 6223 | 0.8532 | 0.8974 | MN20160304_L02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 47.83 | 770.25 | 4826 | 6223 | 0.7755 | 0.8382 | MN20160304_L02 | G06 |